What distinguishes GHK-Cu from BPC-157 in the literature?
The short answer
Answered from published research literature only. It describes what that literature examines; it is not a statement about use in people. GHK-Cu and BPC-157 are investigational research material and are not approved products.
They are examined through different mechanisms. GHK-Cu work concerns a copper-coordinating tripeptide and matrix-protein expression; BPC-157 work concerns nitric-oxide–system signalling and blood-vessel formation.1864422523782145
The study material differs as well: the GHK-Cu record is largely cell culture, while the BPC-157 record is largely rodent preparations.2623673021030672
Cited literature
- The human tri-peptide GHK and tissue remodelingPickart L · Journal of Biomaterials Science, Polymer Edition · 2008PMID 18644225 ↗
- BPC 157 and blood vesselsSeiwerth S, et al. · Current Pharmaceutical Design · 2014PMID 23782145 ↗
- GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin RegenerationPickart L, Vasquez-Soltero JM, Margolina A · BioMed Research International · 2015PMID 26236730 ↗
- The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migrationChang CH, et al. · Journal of Applied Physiology · 2011PMID 21030672 ↗
Research-literature characterization, provided for research context only. For laboratory research use only. Not for human consumption.